Small Cap Biotech
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Trend Stats
1-Month Return
+0.51%
3-Month Return
+13.02%
12-Month Return
+72.55%
Volatility Score
2.8
RSI
48.6
ST Trend
Up
LT Trend
Up
Short-Term Trend
Up
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Small Cap Biotech
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | $458B | +40.53% | +31.45% | +11.20% | 2.5 | Up | Up |
| AMGN | Amgen | $203B | +26.34% | +9.96% | +7.00% | 2.3 | Up | Up |
| GILD | Gilead Sciences | $161B | +14.18% | -0.18% | +3.32% | 3.1 | Neutral | Down |
| VRTX | Vertex Pharma | $121B | +1.64% | +10.94% | +0.45% | 3.2 | Neutral | Up |
| REGN | Regeneron Pharma | $69B | +17.14% | -12.58% | +5.23% | 2.5 | Neutral | Down |
| RVMD | REVOLUTION MEDIC | $40B | +399.22% | +39.86% | +11.46% | 4.0 | Up | Up |
| NTRA | Natera | $38B | +88.62% | +28.58% | +0.78% | 4.2 | Up | Up |
| ALNY | Alnylam Pharma | $36B | -17.35% | -11.05% | -7.58% | 5.2 | Down | Down |
| BIIB | Biogen | $30B | +53.73% | +9.66% | +1.30% | 4.3 | Neutral | Up |
| UTHR | United Therapeut | $26B | +73.55% | -6.82% | -3.90% | 2.6 | Down | Up |
| ROIV | ROIVANT SCIENCES | $25B | +203.12% | +27.73% | +2.94% | 3.1 | Up | Up |
| INCY | Incyte | $24B | +67.62% | +24.32% | +8.49% | 2.9 | Up | Up |
| INSM | Insmed | $23B | +2.86% | -20.90% | +3.34% | 4.0 | Neutral | Down |
| MRNA | MODERNA | $21B | +58.33% | +6.58% | -10.51% | 8.7 | Down | Up |
| NBIX | Neurocrine Biosc | $18B | +33.02% | +37.66% | +5.85% | 2.8 | Up | Up |
| BBIO | BRIDGEBIO PHARMA | $16B | +81.47% | +14.66% | +21.14% | 4.0 | Up | Up |
| EXEL | Exelixis | $14B | +21.43% | +23.21% | +4.73% | 2.7 | Up | Up |
| MDGL | Madrigal Pharmct | $13B | +82.48% | +6.27% | +6.82% | 4.0 | Up | Up |
| ARWR | Arrowhead Phrmct | $12B | +443.84% | +15.82% | +7.25% | 5.6 | Up | Up |
| BMRN | Biomarin Pharm | $11B | +0.54% | +11.56% | +3.49% | 2.6 | Up | Up |
| CYTK | Cytokinetics | $11B | +117.16% | +23.61% | -0.57% | 3.8 | Up | Up |
| SMMT | SUMMIT THERAP | $11B | -52.35% | -38.13% | -4.14% | 5.7 | Down | Down |
| APGE | APOGEE THERAP | $10B | +228.96% | +56.85% | +1.20% | 0.3 | Up | Up |
| KRYS | KRYSTAL BIOTECH | $9.9B | +127.08% | +23.00% | -3.58% | 4.7 | Neutral | Up |
| HALO | Halozyme Therape | $9.7B | +40.68% | +25.35% | +15.15% | 3.2 | Up | Up |
| IONS | Ionis Pharmaceut | $9.3B | +33.86% | -22.82% | -26.10% | 6.3 | Down | Down |
| KYMR | KYMERA THERAP | $9.1B | +141.47% | +30.22% | +10.71% | 6.6 | Up | Up |
| PRAX | PRAXIS PRECIS | $9.1B | +449.31% | -5.66% | +5.30% | 6.2 | Up | Up |
| SYRE | Spyre Therap | $8.9B | +474.09% | +46.59% | +18.43% | 5.6 | Up | Up |
| ALKS | Alkermes | $8.8B | +102.41% | +58.78% | +4.84% | 3.7 | Up | Up |
| PTGX | Protagonist Ther | $8.8B | +146.80% | +36.11% | +11.43% | 4.7 | Up | Up |
| TGTX | TG Therap | $8.6B | +51.87% | +53.03% | +4.55% | 4.4 | Up | Up |
| IMVT | IMMUNOVANT | $8.1B | +132.51% | +37.89% | +3.11% | 3.6 | Up | Up |
| PCVX | VAXCYTE | $7.9B | +49.22% | -8.12% | +1.47% | 4.6 | Up | Up |
| IBRX | IMMUNITYBIO | $7.4B | +148.25% | -4.57% | -8.97% | 8.0 | Down | Up |
| RYTM | RHYTHM PHARM | $7B | +18.10% | +19.14% | -5.07% | 4.1 | Up | Up |
| MIRM | MIRUM REG S-AI | $6.9B | +118.08% | +23.54% | -1.69% | 5.0 | Up | Up |
| COGT | COGENT BIOSCIS | $6.8B | +229.41% | +8.01% | +5.94% | 4.4 | Up | Up |
| ERAS | ERASCA | $6.6B | +998.28% | -11.07% | +26.98% | 6.9 | Up | Up |
| PTCT | PTC Therapeutics | $6.4B | +71.70% | +12.59% | -8.99% | 4.3 | Down | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |